Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having. Read more about Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having.
Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone. Read more about Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone.
Groundwater constituents and the incidence of kidney cancer. Read more about Groundwater constituents and the incidence of kidney cancer.
Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Read more about Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial. Read more about Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma. Read more about Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myeloma.
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study. Read more about The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study.
Lower leukemia burden maximizes the impact of blinatumomab therapy. Read more about Lower leukemia burden maximizes the impact of blinatumomab therapy.
Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis. Read more about Ethnic disparities in childhood leukemia survival by border residence: A Texas population-based analysis.
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status. Read more about Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status.
